Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,402.50
-468.00 (-7.97%)
At close: Feb 13, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 645.95 billion as of February 13, 2026. Its market cap has increased by 8.86% in one year.
Market Cap
645.95B
Enterprise Value
622.64B
Revenue
142.53B
Ranking
n/a
PE Ratio
27.24
Stock Price
5,402.50
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 645.95B, an increase of 291.00%. That is a compound annual growth rate of 14.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 645.95B | -1.89% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.64T |
| Cipla | 1.07T |
| Zydus Lifesciences | 926.69B |
| Mankind Pharma | 858.22B |
| Aurobindo Pharma | 672.51B |
| Glenmark Pharmaceuticals | 574.14B |
| Laurus Labs | 545.58B |
| Ipca Laboratories | 373.68B |